You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 12, December 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  EXPEDITED PUBLICATION
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Photocoagulation for Diabetic Macular Edema

Early Treatment Diabetic Retinopathy Study Report Number 1 Early Treatment Diabetic Retinopathy Study Research Group

Arch Ophthalmol. 1985;103(12):1796-1806.


Abstract

• Data from the Early Treatment Diabetic Retinopathy Study (ETDRS) show that focal photocoagulation of "clinically significant" diabetic macular edema substantially reduces the risk of visual loss. Focal treatment also increases the chance of visual improvement, decreases the frequency of persistent macular edema, and causes only minor visual field losses. In this randomized clinical trial, which was supported by the National Eye Institute, 754 eyes that had macular edema and mild to moderate diabetic retinopathy were randomly assigned to focal argon laser photocoagulation, while 1,490 such eyes were randomly assigned to deferral of photocoagulation. The beneficial effects of treatment demonstrated in this trial suggest that all eyes with clinically significant diabetic macular edema should be considered for focal photocoagulation. Clinically significant macular edema is defined as retinal thickening that involves or threatens the center of the macula (even if visual acuity is not yet reduced) and is assessed by stereo contact lens biomicroscopy or stereo photography. Follow-up of all ETDRS patients continues without other modifications in the study protocol.



Footnotes

Accepted for publication Sept 27, 1985.

A complete listing of the participants in this research study appears at the end of this article.

Reprint requests to the Biometry & Epidemiology Program, National Eye Institutes, Bldg 31, Room 6A24, 9000 Rockville Pike, Bethesda, MD 20892.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rates of Progression in Diabetic Retinopathy During Different Time Periods: A systematic review and meta-analysis
Wong et al.
Diabetes Care 2009;32:2307-2313.
ABSTRACT | FULL TEXT  

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy
Gonzalez et al.
Br J Ophthalmol 2009;93:1474-1478.
ABSTRACT | FULL TEXT  

Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema
Figueira et al.
Br J Ophthalmol 2009;93:1341-1344.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy Screening Update
Garg and Davis
Clin. Diabetes 2009;27:140-145.
ABSTRACT | FULL TEXT  

Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation
Kim et al.
Br J Ophthalmol 2009;93:901-905.
ABSTRACT | FULL TEXT  

Posterior Juxtascleral Infusion of Modified Triamcinolone Acetonide Formulation for Refractory Diabetic Macular Edema: One-Year Follow-Up
Veritti et al.
IOVS 2009;50:2391-2397.
ABSTRACT | FULL TEXT  

Fundus autofluorescence and Fourier-domain optical coherence tomography imaging of 10 and 20 millisecond Pascal retinal photocoagulation treatment
Muqit et al.
Br J Ophthalmol 2009;93:518-525.
ABSTRACT | FULL TEXT  

Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings
Diabetic Retinopathy Clinical Research Network
Arch Ophthalmol 2009;127:132-140.
ABSTRACT | FULL TEXT  

Vascular endothelial growth factor Trap-Eye for diabetic macular oedema
Kaiser
Br J Ophthalmol 2009;93:135-136.
FULL TEXT  

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
Duckworth et al.
NEJM 2009;360:129-139.
ABSTRACT | FULL TEXT  

Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema
Davis et al.
IOVS 2009;50:1-4.
ABSTRACT | FULL TEXT  

Standards of Medical Care in Diabetes--2009
American Diabetes Association
Diabetes Care 2009;32:S13-S61.
FULL TEXT  

Prolonged Effect of Intensive Therapy on the Risk of Retinopathy Complications in Patients With Type 1 Diabetes Mellitus: 10 Years After the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial/Epidemiol
Arch Ophthalmol 2008;126:1707-1715.
ABSTRACT | FULL TEXT  

Resource Use and Costs Associated With Diabetic Macular Edema in Elderly Persons
Shea et al.
Arch Ophthalmol 2008;126:1748-1754.
ABSTRACT | FULL TEXT  

Interventions for diabetic macular oedema: a systematic review of the literature
O'Doherty et al.
Br J Ophthalmol 2008;92:1581-1590.
ABSTRACT | FULL TEXT  

A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data
Gangnon et al.
IOVS 2008;49:5041-5047.
ABSTRACT | FULL TEXT  

Evaluation of Time Domain and Spectral Domain Optical Coherence Tomography in the Measurement of Diabetic Macular Edema
Forooghian et al.
IOVS 2008;49:4290-4296.
ABSTRACT | FULL TEXT  

Rosiglitazone and Delayed Onset of Proliferative Diabetic Retinopathy
Shen et al.
Arch Ophthalmol 2008;126:793-799.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema
Ockrim et al.
Br J Ophthalmol 2008;92:795-799.
ABSTRACT | FULL TEXT  

Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in Eyes with Diabetic Macular Edema
Davis et al.
IOVS 2008;49:1745-1752.
ABSTRACT | FULL TEXT  

The potential of digital monochrome images versus colour slides in telescreening for diabetic retinopathy
Johansen et al.
J Telemed Telecare 2008;14:27-31.
ABSTRACT | FULL TEXT  

The English national screening programme for sight-threatening diabetic retinopathy
Scanlon
J Med Screen 2008;15:1-4.
ABSTRACT | FULL TEXT  

Vision-related quality of life in patients with diabetic macular oedema
Hariprasad et al.
Br J Ophthalmol 2008;92:89-92.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
Paccola et al.
Br J Ophthalmol 2008;92:76-80.
ABSTRACT | FULL TEXT  

Standards of Medical Care in Diabetes--2008
American Diabetes Association
Diabetes Care 2008;31:S12-S54.
FULL TEXT  

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema
Knudsen et al.
Br J Ophthalmol 2007;91:1593-1595.
ABSTRACT | FULL TEXT  

Optical Coherence Tomography versus Stereoscopic Fundus Photography or Biomicroscopy for Diagnosing Diabetic Macular Edema: A Systematic Review
Virgili et al.
IOVS 2007;48:4963-4973.
ABSTRACT | FULL TEXT  

The role of heredity in determining central retinal thickness
Liew et al.
Br J Ophthalmol 2007;91:1143-1147.
ABSTRACT | FULL TEXT  

Screening for and managing diabetic retinopathy: Current approaches
Bloomgarden
Am J Health Syst Pharm 2007;64:S8-S14.
ABSTRACT | FULL TEXT  

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

Six-Year Incidence of Visual Loss in African Americans With Type 1 Diabetes Mellitus: The New Jersey 725
Roy and Skurnick
Arch Ophthalmol 2007;125:1061-1067.
ABSTRACT | FULL TEXT  

Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study
Al-Kateb et al.
Diabetes 2007;56:2161-2168.
ABSTRACT | FULL TEXT  

Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema?
Iida
Br J Ophthalmol 2007;91:407-408.
FULL TEXT  

Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema
Shimura et al.
Br J Ophthalmol 2007;91:449-454.
ABSTRACT | FULL TEXT  

Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema
Kuppermann et al.
Arch Ophthalmol 2007;125:309-317.
ABSTRACT | FULL TEXT  

A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema
Lam et al.
Br J Ophthalmol 2007;91:199-203.
ABSTRACT | FULL TEXT  

Multifactorial Interventions Before Laser Photocoagulation Improve Outcome of Diabetic Macular Edema
Singh et al.
Diabetes Care 2006;29:2758-2759.
FULL TEXT  

The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy
Ahmed et al.
Diabetes Care 2006;29:2205-2209.
ABSTRACT | FULL TEXT  

Six-year progression of retinopathy and associated risk factors in african american patients with type 1 diabetes mellitus: the new jersey 725.
Roy and Affouf
Arch Ophthalmol 2006;124:1297-1306.
ABSTRACT | FULL TEXT  

Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema
Chan et al.
Br J Ophthalmol 2006;90:1137-1141.
ABSTRACT | FULL TEXT  

Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Bandello et al.
Arch Ophthalmol 2006;124:643-650.
ABSTRACT | FULL TEXT  

Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema.
Kang et al.
Arch Ophthalmol 2006;124:653-658.
ABSTRACT | FULL TEXT  

Retinal Hemodynamics in Early Diabetic Macular Edema
Guan et al.
Diabetes 2006;55:813-818.
ABSTRACT | FULL TEXT  

The Repeatability of Best Corrected Acuity in Normal and Amblyopic Children 4 to 12 Years of Age
Chen et al.
IOVS 2006;47:614-619.
ABSTRACT | FULL TEXT  

Effect of Perioperative Glycemic Control in Progression of Diabetic Retinopathy and Maculopathy
Suto et al.
Arch Ophthalmol 2006;124:38-45.
ABSTRACT | FULL TEXT  

Prevention of diabetic blindness
Stefansson
Br J Ophthalmol 2006;90:2-3.
FULL TEXT  

Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement
Pierre-Kahn et al.
Br J Ophthalmol 2005;89:1581-1585.
ABSTRACT | FULL TEXT  

Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial
Bonini-Filho et al.
IOVS 2005;46:3845-3849.
ABSTRACT | FULL TEXT  

Effect of Ruboxistaurin on Blood-Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema
Strom et al.
IOVS 2005;46:3855-3858.
ABSTRACT | FULL TEXT  

Metabolic Control of Diabetes Is Associated With an Improved Response of Diabetic Retinopathy to Panretinal Photocoagulation
Kotoula et al.
Diabetes Care 2005;28:2454-2457.
ABSTRACT | FULL TEXT  

Repeatability and Reproducibility of Fast Macular Thickness Mapping With Stratus Optical Coherence Tomography
Polito et al.
Arch Ophthalmol 2005;123:1330-1337.
ABSTRACT | FULL TEXT  

Predictive Factors for Visual Acuity After Intravitreal Triamcinolone Treatment for Diabetic Macular Edema
Jonas et al.
Arch Ophthalmol 2005;123:1338-1343.
ABSTRACT | FULL TEXT  

Intravitreal triamcinolone acetonide for refractory diabetic macular oedema
Fernando and Pandit
JRSM 2005;98:421-422.
FULL TEXT  

An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme
Scanlon et al.
Br J Ophthalmol 2005;89:971-975.
ABSTRACT | FULL TEXT  

Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema
Spandau et al.
Br J Ophthalmol 2005;89:999-1003.
ABSTRACT | FULL TEXT  

Overnight Thickness Variation in Diabetic Macular Edema
Larsen et al.
IOVS 2005;46:2313-2316.
ABSTRACT | FULL TEXT  

Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I
Rema et al.
IOVS 2005;46:2328-2333.
ABSTRACT | FULL TEXT  

The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
The PKC-DRS Study Group
Diabetes 2005;54:2188-2197.
ABSTRACT | FULL TEXT  

"Light" versus "classic" laser treatment for clinically significant diabetic macular oedema
Bandello et al.
Br J Ophthalmol 2005;89:864-870.
ABSTRACT | FULL TEXT  

The impact of the Health Technology Board for Scotland's grading model on referrals to ophthalmology services
Philip et al.
Br J Ophthalmol 2005;89:891-896.
ABSTRACT | FULL TEXT  

Cyclosporine vs Tacrolimus Therapy for Posterior and Intermediate Uveitis
Murphy et al.
Arch Ophthalmol 2005;123:634-641.
ABSTRACT | FULL TEXT  

Need for Eye Care Among Older Adults With Diabetes Mellitus in Fee-for-Service and Managed Medicare
Brown et al.
Arch Ophthalmol 2005;123:669-675.
ABSTRACT | FULL TEXT  

Perceived Barriers to Diabetic Eye Care: Qualitative Study of Patients and Physicians
Hartnett et al.
Arch Ophthalmol 2005;123:387-391.
ABSTRACT | FULL TEXT  

Addition of Primary Care-Based Retinal Imaging Technology to an Existing Eye Care Professional Referral Program Increased the Rate of Surveillance and Treatment of Diabetic Retinopathy
Wilson et al.
Diabetes Care 2005;28:318-322.
ABSTRACT | FULL TEXT  

Intravitreal Triamcinolone Acetonide for Macular Edema Associated With Diabetic Retinopathy and Venous Occlusive Disease: It's Time for Clinical Trials
Flynn and Scott
Arch Ophthalmol 2005;123:258-259.
FULL TEXT  

Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association
Silverstein et al.
Diabetes Care 2005;28:186-212.
FULL TEXT  

Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema
Luttrull et al.
Br J Ophthalmol 2005;89:74-80.
ABSTRACT | FULL TEXT  

A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema
Thomas et al.
Br J Ophthalmol 2005;89:81-86.
ABSTRACT | FULL TEXT  

Vitreous Levels of Vascular Endothelial Growth Factor and Stromal-Derived Factor 1 in Patients With Diabetic Retinopathy and Cystoid Macular Edema Before and After Intraocular Injection of Triamcinolone
Brooks et al.
Arch Ophthalmol 2004;122:1801-1807.
ABSTRACT | FULL TEXT  

Acute orbital effects of retrobulbar injection on optic nerve head topography
Akar et al.
Br J Ophthalmol 2004;88:1573-1576.
ABSTRACT | FULL TEXT  

Is Intensive Management of Blood Pressure to Prevent Visual Loss in Persons With Type 2 Diabetes Indicated?
Klein
Arch Ophthalmol 2004;122:1707-1709.
FULL TEXT  

Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study
Ciardella et al.
Br J Ophthalmol 2004;88:1131-1136.
ABSTRACT | FULL TEXT  

Subthreshold micropulse diode laser treatment in diabetic macular oedema
Laursen et al.
Br J Ophthalmol 2004;88:1173-1179.
ABSTRACT | FULL TEXT  

Intravitreal Injection of Triamcinolone: An emerging treatment for diabetic macular edema
Ip
Diabetes Care 2004;27:1794-1797.
FULL TEXT  

Coats' disease in a vegetarian female
Ciardella et al.
Br J Ophthalmol 2004;88:970-971.
FULL TEXT  

Reproducibility of Nerve Fiber Thickness, Macular Thickness, and Optic Nerve Head Measurements Using StratusOCT
Paunescu et al.
IOVS 2004;45:1716-1724.
ABSTRACT | FULL TEXT  

Comparison of Objective Retinal Thickness Analysis and Subjective Stereo Fundus Photography in Diabetic Macular Edema
Strom and Sander
IOVS 2004;45:1450-1455.
ABSTRACT | FULL TEXT  

Causes and Prevalence of Visual Impairment Among Adults in the United States
The Eye Diseases Prevalence Research Group
Arch Ophthalmol 2004;122:477-485.
ABSTRACT | FULL TEXT  

The Prevalence of Diabetic Retinopathy Among Adult Type 1 Diabetic Persons in the United States
Roy et al.
Arch Ophthalmol 2004;122:546-551.
ABSTRACT | FULL TEXT  

The Prevalence of Diabetic Retinopathy Among Adults in the United States
Arch Ophthalmol 2004;122:552-563.
 

Health promotion and health education about diabetes mellitus
Anthony et al.
The Journal of the Royal Society for the Promotion of Health 2004;124:70-73.
ABSTRACT  

Supplemental Oxygen Improves Diabetic Macular Edema: A Pilot Study
Nguyen et al.
IOVS 2004;45:617-624.
ABSTRACT | FULL TEXT  

Intravitreal Reinjection of Triamcinolone for Exudative Age-Related Macular Degeneration
Jonas et al.
Arch Ophthalmol 2004;122:218-222.
ABSTRACT | FULL TEXT  

Surgery for Idiopathic Full-Thickness Macular Hole: Two-Year Results of a Randomized Clinical Trial Comparing Natural History, Vitrectomy, and Vitrectomy Plus Autologous Serum: Moorfields Macular Hole Study Group Report No. 1
Ezra and Gregor
Arch Ophthalmol 2004;122:224-236.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Frank
NEJM 2004;350:48-58.
FULL TEXT  

The Relation of Retinal Vessel Caliber to the Incidence and Progression of Diabetic Retinopathy: XIX: The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein et al.
Arch Ophthalmol 2004;122:76-83.
ABSTRACT | FULL TEXT  

Changes in Focal Macular Electroretinograms and Foveal Thickness after Vitrectomy for Diabetic Macular Edema
Terasaki et al.
IOVS 2003;44:4465-4472.
ABSTRACT | FULL TEXT  

Tele-Screening for Diabetic Retinopathy With the Retinal Thickness Analyzer
Neubauer et al.
Diabetes Care 2003;26:2890-2897.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
Ciulla et al.
Diabetes Care 2003;26:2653-2664.
ABSTRACT | FULL TEXT  

Repeatability of ETDRS Visual Acuity in Children
Manny et al.
IOVS 2003;44:3294-3300.
ABSTRACT | FULL TEXT  

Telemedicine Improves Eye Examination Rates in Individuals With Diabetes: A model for eye-care delivery in underserved communities
Davis et al.
Diabetes Care 2003;26:2476-2476.
FULL TEXT  

Laser management of diabetic retinopathy
Dowler
JRSM 2003;96:277-279.
FULL TEXT  

Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital
Lai et al.
Br J Ophthalmol 2003;87:385-390.
ABSTRACT | FULL TEXT  

Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema
Hudson et al.
Br J Ophthalmol 2003;87:455-461.
ABSTRACT | FULL TEXT  

Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis
Maberley et al.
CMAJ 2003;168:160-164.
ABSTRACT | FULL TEXT  

Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema
Jonas et al.
Arch Ophthalmol 2003;121:57-61.
ABSTRACT | FULL TEXT  

Consistency Between Visual Acuity Scores Obtained at Different Test Distances: Theory vs Observations in Multiple Studies
Dong et al.
Arch Ophthalmol 2002;120:1523-1533.
ABSTRACT | FULL TEXT  

Can a cilio-retinal artery influence diabetic maculopathy?
Knudsen and Lervang
Br J Ophthalmol 2002;86:1252-1255.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.